midazolam has been researched along with Aprosodia in 2 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Alami, AA | 1 |
| Matson, AM | 1 |
| Thurlow, AC | 1 |
2 other studies available for midazolam and Aprosodia
| Article | Year |
|---|---|
Successful treatment of early ropivacaine toxicity with intralipid in a patient with attention deficit hyperactivity disorder.
Topics: Adolescent; Amides; Anesthesia, General; Anesthetics, Local; Arthroscopy; Atomoxetine Hydrochloride; | 2011 |
Hypotension and neurological sequelae following intramuscular midazolam.
Topics: Aged; Dysarthria; Humans; Hypotension; Male; Midazolam; Preanesthetic Medication; Sleep Stages; Spee | 1988 |